French drugmaker Sanofi on Friday increased its guidance for full-year earnings, citing strong sales of anti-inflammatory treatment Dupixent and closely-watched new drug launches.
on Friday increased its guidance for full-year earnings, citing strong sales of anti-inflammatory treatment Dupixent and closely-watched new drug launches.
It had previously said it expected 2023 adjusted earnings per share to grow by a "low single-digit" percentage, with an additional negative currency impact of between 5.5% and 6.5%.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Skittles and French's officially make mustard-flavored candy a thing for National Mustard DayPeople brave enough to try the new flavor can do that at French's 'Mustard Mobile' that's stopping in three US cities next week.
Read more »
Skittles and French's officially make mustard-flavored candy a thing for National Mustard DayPeople brave enough to try the new flavor can do that at French's 'Mustard Mobile' that's stopping in three US cities next week.
Read more »
Skittles and French's officially make mustard-flavored candy a thing for National Mustard DayPeople brave enough to try the new flavor can do that at French's 'Mustard Mobile' that's stopping in three US cities next week.
Read more »
Skittles and French's officially make mustard-flavored candy a thing for National Mustard DayPeople brave enough to try the new flavor can do that at French's 'Mustard Mobile' that's stopping in three US cities next week.
Read more »
Skittles and French's officially make mustard-flavored candy a thing for National Mustard DayPeople brave enough to try the new flavor can do that at French's 'Mustard Mobile' that's stopping in three US cities next week.
Read more »